Corey S. Cutler, MD, MPH, FRCPC
Advertisement
Corey Cutler, MD, MPH, FRCPC, is the director of the Adult Stem Cell Transplantation Program, director of Clinical Research Stem Cell Transplantation, and director of Stem Cell Transplantation Survivorship Program Institute at Dana-Farber Cancer Institute.
Articles by Corey S. Cutler, MD, MPH, FRCPC
Corey S. Cutler, MD, MPH, FRCPC, provides insight on the case of a 49-year-old man with chronic GVHD and reviews current and emerging treatment options for disease management.
Corey S. Cutler, MD, MPH, discusses the current treatment options for patients with chronic graft-versus-host-disease and highlighted some upcoming research.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival
2
Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma
3
Safusidenib Shows Durable Responses in IDH1-Mutant Glioma at 3-Year Follow-Up
4
Thoracic Radiotherapy Added to Atezolizumab Raised Toxicity in SCLC
5